Guggenheim Capital LLC Buys Shares of 14,980 Fresenius Medical Care AG (NYSE:FMS)

Guggenheim Capital LLC bought a new stake in shares of Fresenius Medical Care AG (NYSE:FMS - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 14,980 shares of the company's stock, valued at approximately $339,000.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Smartleaf Asset Management LLC boosted its position in Fresenius Medical Care by 192.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company's stock valued at $28,000 after purchasing an additional 806 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of Fresenius Medical Care during the 3rd quarter valued at about $38,000. Russell Investments Group Ltd. grew its stake in shares of Fresenius Medical Care by 234.1% in the 4th quarter. Russell Investments Group Ltd. now owns 3,151 shares of the company's stock valued at $71,000 after buying an additional 2,208 shares in the last quarter. Jones Financial Companies Lllp increased its holdings in Fresenius Medical Care by 80.5% in the fourth quarter. Jones Financial Companies Lllp now owns 4,510 shares of the company's stock worth $102,000 after buying an additional 2,012 shares during the last quarter. Finally, Venturi Wealth Management LLC raised its position in Fresenius Medical Care by 8.4% during the fourth quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company's stock valued at $129,000 after acquiring an additional 441 shares in the last quarter. 8.37% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. StockNews.com raised shares of Fresenius Medical Care from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, February 5th. Truist Financial increased their target price on shares of Fresenius Medical Care from $23.00 to $25.00 and gave the stock a "hold" rating in a research report on Monday, January 6th.

Fresenius Medical Care Stock Performance

Shares of NYSE:FMS traded up $0.61 during trading on Friday, reaching $25.63. The stock had a trading volume of 392,035 shares, compared to its average volume of 317,072. The stock has a fifty day simple moving average of $24.11 and a two-hundred day simple moving average of $23.14. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42. Fresenius Medical Care AG has a 52 week low of $17.93 and a 52 week high of $26.04. The firm has a market capitalization of $15.04 billion, a price-to-earnings ratio of 21.21, a P/E/G ratio of 0.76 and a beta of 0.93.

Fresenius Medical Care Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.